Access to anti-retroviral drugs, female in Egypt
Egypt: Access to anti-retroviral drugs, female was 46.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Egypt, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Egypt stood at 46.0%. That is the highest value across all 25 years on record.
That represents a change of up 17.9% on the previous year and up 360.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Egypt peaked at 46.0% in 2024 and was at its lowest, 0.0%, in 2000.
Egypt ranks 125th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Egypt, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 1.0% | — |
| 2010 | 3.0% | +200.0% |
| 2011 | 4.0% | +33.3% |
| 2012 | 5.0% | +25.0% |
| 2013 | 7.0% | +40.0% |
| 2014 | 10.0% | +42.9% |
| 2015 | 12.0% | +20.0% |
| 2016 | 16.0% | +33.3% |
| 2017 | 23.0% | +43.8% |
| 2018 | 30.0% | +30.4% |
| 2019 | 30.0% | +0.0% |
| 2020 | 30.0% | +0.0% |
| 2021 | 33.0% | +10.0% |
| 2022 | 36.0% | +9.1% |
| 2023 | 39.0% | +8.3% |
| 2024 | 46.0% | +17.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.1% | 0.0% | 1.0% | 10 |
| 2010s | 14.0% | 3.0% | 30.0% | 10 |
| 2020s | 36.8% | 30.0% | 46.0% | 5 |
Countries ranked near Egypt
- 122 Angola 50.0% compare
- 123 North Macedonia 49.0% compare
- 124 Malta 47.0% compare
- 126 Qatar 43.0% compare
- 127 Syrian Arab Republic 41.0% compare
- 128 Madagascar 39.0% compare
More gender data for Egypt
- Child population (UN estimates and projections) 36,649 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.6533 % change on previous year (2030)
- Population 90,490 (2030)
- Working-age population (UN estimates and projections) 90,490 (2030)
- Population (UN estimates and projections), annual growth rate 2.27 % change on previous year (2030)
- Age population, age 00, female, interpolated 1.18 million (2025)
- Age population, age 00, male, interpolated 1.24 million (2025)
- Age population, age 01, female, interpolated 1.17 million (2025)
- Age population, age 01, male, interpolated 1.23 million (2025)
- Age population, age 02, female, interpolated 1.15 million (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Egypt?
- Access to anti-retroviral drugs, female in Egypt was 46.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Egypt?
- The highest recorded value was 46.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Egypt?
- The lowest recorded value was 0.0% in 2000.
- How does Egypt rank for access to anti-retroviral drugs, female?
- Egypt ranks 125th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Egypt?
- Over the last ten years it is up 360.0%. The long-run trend across the full record is volatile.
- Where does this Egypt data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.